Acute myeloblastic leukemia physical examination
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
References
Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CFU-GM/ and other granulocytes |
| ||||||||||||||
| MEP |
| ||||||||||||||
| CFU-Mast | Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis) | ||||||||||||||
| Multiple/unknown | AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia | ||||||||||||||
| See also hematology, lymphoid malignancy | |||||||||||||||
This article includes text from the U.S. National Cancer Institute's public domain Dictionary of Cancer Terms
Myeloid Hematological malignancy/leukemia histology (ICD-O 9590-9989, C81-C96, 200-208) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CFU-GM/ and other granulocytes |
| ||||||||||||||
| MEP |
| ||||||||||||||
| CFU-Mast | Mastocytoma (Mast cell leukemia, Mast cell sarcoma, Systemic mastocytosis) | ||||||||||||||
| Multiple/unknown | AML (Acute panmyelosis with myelofibrosis, Myeloid sarcoma) · MP (Myelofibrosis) · Acute biphenotypic leukaemia | ||||||||||||||
| See also hematology, lymphoid malignancy | |||||||||||||||
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies